Results 91 to 100 of about 1,518,675 (340)
Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine [PDF]
, 2021 This background document was prepared by the Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 Vaccines to inform the discussions of SAGE at its 15 March 2021 meeting, which resulted in the issuance of the WHO interim ...
World Health Organisation SAGE Working Group on COVID-19 Vaccine
core
Arthritis Care &Research, EarlyView.Objective Several case reports have proposed a potential association between COVID‐19 vaccination and the subsequent development of idiopathic inflammatory myositis (IIM). This study examined prior COVID‐19 vaccination in US veterans who developed new‐onset IIM compared to those without new‐onset IIM.
Caleb Hernández +10 more
wiley +1 more source
Health disparities in chronic liver disease
Hepatology, EarlyView., 2022 Abstract The syndemic of hazardous alcohol consumption, opioid use, and obesity has led to important changes in liver disease epidemiology that have exacerbated health disparities. Health disparities occur when plausibly avoidable health differences are experienced by socially disadvantaged populations.
Ani Kardashian +3 more
wiley +1 more source
Rapid development of a registry to accelerate COVID-19 vaccine clinical trials
npj Digital MedicineResponse to the SARS-Cov-2 pandemic required the unprecedented, rapid activation of the COVID-19 Prevention Network (CoVPN) representing hundreds of sites conducting vaccine clinical trials.
Neil F. Abernethy +12 more
doaj +1 more source
COVID‐19 vaccine‐related new‐onset lichen planus
Clinical Case Reports, 2022 Coronavirus disease 2019 (COVID‐19) vaccines significantly impacted world health and well‐being. However, various adverse events have been observed following severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccination.
Arefeh Babazadeh +6 more
doaj +1 more source
Vaccine Apartheid: A Human Rights Analysis of COVID-19 Vaccine Inequity (Working paper)
, 2021 In this paper, we analyse vaccine inequity under international human rights law. In Part 1, we introduce the currently available COVID-19 vaccines, before discussing causes and consequences of vaccine inequity, as well as current efforts to expand global
Dore, Gregory J, Joseph, Sarah
core +1 more source
Advanced Functional Materials, EarlyView.We have developed DEX/GM, an all‐natural, personalizable hybrid vaccine designed by coating dendritic cell‐derived exosomes (DEX) onto tumor cell membranes (GM) for sustained prophylaxis against glioblastoma (GBM). ABSTRACT Glioblastoma (GBM), one of the most aggressive and lethal brain tumors, remains incurable with a poor clinical prognosis.
Shanshan Li +6 more
wiley +1 more source
Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening
Hepatology Communications, EarlyView., 2022 Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff +17 more
wiley +1 more source
Vaccines, 2022 We aimed to assess the Iranian people’s attitude and confidence in the COVID-19 vaccine, their concerns about the safety of vaccines, and their reasons for accepting or rejecting the COVID-19 vaccine. We conducted a web-based cross-sectional study with a
Amin Nakhostin-Ansari +10 more
doaj +1 more source
Vaccine, 2021 Background Vaccines for COVID-19 are anticipated to be available by 2021. Vaccine uptake rate is a crucial determinant for herd immunity. We examined factors associated with acceptance of vaccine based on (1). constructs of the Health Belief Model (HBM),
Martin C.S. Wong +11 more
semanticscholar +1 more source